Guntupalli K, Dean N, Morris PE, Bandi V, Margolis B, Rivers E, Levy M, Lodato RF, Ismail PM, Reese A, Schaumberg JP, Malik R, Dellinger RP. A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis
. Crit Care Med. 2013;41(3):706-716.
Needham DM, Dinglas VD, Morris PE, Jackson JC, Hough CL, Mendez-Tellez PA, Wozniak AW, Colantuoni E, Ely EW, Rice TW, Hopkins RO. Physical and cognitive performance of patients with acute lung injury 1 year after initial trophic versus full enteral feeding. EDEN trial follow-up
. Am J Respir Crit Care Med. 2013;188(5):567-576.
McCrory M, Gower E, Morris P, Simpson S. Off-hours admission and mortality in pediatric intensive care [abstract]. Crit Care Med. 2013;41(12 Suppl 1):A135.
Dhar S, Sarwal A, Files DC, Berry M, Hauser J, Campbell P, Thompson C, Morris P. Muscle ultrasound and short physical performance battery (SPPB) to predict ICU functional outcomes [abstract]. Crit Care Med. 2013;41(12 Suppl 1):A89.
Parry S, Sarwal A, Cartwright M, Morris P Denehy L. Reliability of quantitative muscle ultrasound analysis in the critically ill population [abstract]. Crit Care Med. 2013;41(12 Suppl 1):A108.
Calfee CS, Gallagher D, Abbott J, Thompson BT, Matthay MA, Hite RD, Morris P, Howard A, Nesser A, Perez S, et al. Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance
. Crit Care Med. 2012;40(6):1731-1737.
Morris PE, Zeno B, Bernard AC, Huang X, Das S, Edeki T, Simonson SG, Bernard GR. A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock
. Crit Care. 2012;16(1):R31.
Kelley S, Agarwal S, Parikh N, Erslon M, Morris P. Development of postoperative pulmonary complications after admission to general care floor in elective surgery cases [abstract]. Crit Care Med. 2012;40(12 Suppl):743.
Kelley S, Agarwal S, Parikh N, Erslon M, Morris P. Respiratory insufficiency, arrest and failure among medical patients on the general care floor [abstract]. Crit Care Med. 2012;40(12 Suppl):764.
Kelley S, Agarwal S, Parikh N, Erslon M, Morris P. US hospital cost vs Medicare payment by ventilation status [abstract]. Crit Care Med. 2012;40(12 Suppl):713.
Morris P, Zeno B, Bernard A, Huang X, Simonson S, Bernard G. Safety and tolerability of an ovine-derived polyclonal anti-TNFalpha Fab fragment (AZD9773) in patients with severe sepsis [abstract]. Crit Care. 2011;15(Suppl 1):S93.
Morris PE, Griffin L, Berry M, Thompson C, Hite RD, Winkelman C, Ross A, Dixon L, Leach S, Haponik E, et al. Receiving early mobility during an intensive care unit admission is a predictor of improved outcomes in acute respiratory failure
. Am J Med Sci. 2011;341(5):373-377.
Crawford J, Guntupalli KK, Dean NC, Morris PE, Malik RK, Schaunberg JP. Talactoferrin alfa (TLF) reduces mortality across a broad range of patients with severe sepsis [abstract]. J Thorac Oncol. 2011;6(6 Suppl 2):S1487.
Guntupalli KK, Dean NC, Morris PE, Bandi V, Margolis BD, Rivers E, Levy MM, Lodato RF, Schaumberg J, Malik RK, et al. Talactoferrin alfa reduces mortality in severe sepsis: results of a phase 2 randomized, placebo-controlled, double-blind study [abstract]. Am J Respir Crit Care Med. 2010;181(1 Meeting Abstracts):A6768.
Hite RD, Seeds MC, Morris PE, Grier BL, Waite BM, Douglas IS, Hudson LD, Goodman RB. Regulation of secretory A2 phospholipase activity in persistent ARDS [abstract]. Am J Respir Crit Care Med. 2010;181():A6474.
Morris PE, Promes JT, Guntupalli KK, Wright PE, Arons MM. A multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults
. Crit Care. 2010;14(3):R125.
Lanspa M, Brown S, Grissom C, Morris P, Malik R, Pittman J, Dean N. Talactoferrin may confer increased survival in patients with septic shock and systolic cardiac dysfunction [abstract]. Crit Care Med. 2010;38(12 Suppl):Abstr 757.
Levy M, Guntupalli K, Dellinger R, Dean N, Morris P, Bandi V, Margolis B, Rivers E, Lodato R, Schaumberg J. Talactoferrin alfa reduces 3 and 6 month all-cause mortality in patients with severe sepsis [abstract]. Crit Care Med. 2010;38(12 Suppl):abstr 26.
Morris PE, Goad A, Thompson C, Taylor K, Harry B, Passmore L, Ross A, Howard A, Hite RD, Haponik E, et al. Early intensive care unit mobility therapy in the treatment of acute respiratory failure
. Crit Care Med. 2008;36(8):2238-2243.
Morris PE. Preface
. Crit Care Clin. 2007;23(1):ix-xi.
Updaw R, Passmore L, Mitten-Long D, Pierce C, Ross A, Wells G, Morris P. Fluid resuscitation volume for septic shock patients was not decreased for echocardiogram-determined left ventricular (LV) systolic dysfunction patients when managed with early goal-directed therapy (EGDT) [abstract]. Chest. 2007;132(4 Suppl):495S.
Daniel A, Owen S, Ross A, Brown J, Ashley A, Bozeman W, Karchmer T, Williamson J, Passmore L, Morris PE, et al. A multi-department strategy for severe sepsis patient resuscitation [abstract]. Crit Care Med. 2006;34(12 Abstr Suppl):A143.
Morris PE, Holbrook A, Thompson C, Ross A, Anderson L, Baker S, Penley L, Daniel A, Howard A, Passmore L, et al. A mobility protocol for acute respiratory failure patients delivered by an ICU mobility team shortens hospital stay [abstract]. Crit Care Med. 2006;34(12 Abstr Suppl):A20.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.